Berenberg Bank set a €95.60 ($113.81) price target on Fresenius Medical Care AG & Co. KGAA (ETR:FME) in a research report sent to investors on Wednesday. The brokerage currently has a buy rating on the stock.

A number of other analysts have also recently commented on the stock. J P Morgan Chase & Co set a €95.60 ($113.81) target price on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a buy rating in a report on Tuesday. Deutsche Bank set a €83.00 ($98.81) target price on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a neutral rating in a report on Friday, December 1st. HSBC set a €85.00 ($101.19) target price on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a neutral rating in a report on Wednesday, November 22nd. S&P Global set a €95.00 ($113.10) target price on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a buy rating in a report on Monday, November 6th. Finally, Credit Suisse Group set a €92.00 ($109.52) target price on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a buy rating in a report on Monday, November 6th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and ten have issued a buy rating to the stock. Fresenius Medical Care AG & Co. KGAA has a consensus rating of Hold and a consensus target price of €89.06 ($106.03).

Fresenius Medical Care AG & Co. KGAA (ETR FME) traded up €0.06 ($0.07) during midday trading on Wednesday, reaching €86.01 ($102.39). 101,039 shares of the company’s stock were exchanged, compared to its average volume of 517,453. Fresenius Medical Care AG & Co. KGAA has a 52 week low of €71.49 ($85.11) and a 52 week high of €89.22 ($106.21).

ILLEGAL ACTIVITY WARNING: This piece was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The correct version of this piece can be accessed at https://theolympiareport.com/2017/12/07/fresenius-medical-care-ag-95-60-price-target-at-berenberg-bank.html.

About Fresenius Medical Care AG & Co. KGAA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGAA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGAA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGAA and related companies with Analyst Ratings Network's FREE daily email newsletter.